General

Biomaterials for 3D Printing

Biomaterial science is one of the major pillars of the successful advancement of 3D printed solutions for healthcare. In this webinar, we invited stakeholders from academia, industry, larger chemical and material companies, and rising startups to give you a comprehensive view of where material science technology for healthcare 3D printing is at. We aim to provide information with enough breadth and depth that is suitable for both the general public and industry experts.

Speakers:

Guillaume de Calan

blank

Guillaume de Calan is founder and CEO of Nanoe, a leading supplier of high tech raw materials for the ceramic industry. Through our brand Zetamix, he also launched the first line of filaments for accessible 3D printing of ceramic and metal parts. At Nanoe, we believe material innovation is at the core of new emerging technologies such as 3D printing, Li Ion batteries, medical implants and many more, and we strive to develop and produce best in class raw materials for these applications.

Rao Bezwada

RAO BEZWADA

An accomplished scientist and entrepreneur, Rao S. Bezwada, Ph.D. established Bezwada Biomedical LLC, an innovation based and technology driven company. The company is focused on developing a wide range of novel absorbable polymeric biomaterials that represent platform technologies capable of enhancing the quality of life by producing next generation bioabsorbable medical devices with therapeutic applications. Dr. Bezwada is the inventor of numerous absorbable technologies including absorbable polyurethanes, absorbable amino acid polymers, absorbable polyester amides, absorbable polyoxaesters and controlled release polymers. Dr Bezwada’s absorbable polyurethane technology is used in FDA approved products, MONTAGE¼, MONTAGE Fast Set Putty, Montage Flowable Putty and PERMATAGE Putty which has been commercialized by Abyrx corporation. In addition, our absorbable polymers are used as bioinks, adhesion prevention barriers, absorbable drug eluting stent coatings, tissue adhesives and sealants, medical device coatings, drug delivery polymers, drug device combinations, absorbable implantable devices and tissue engineering biomaterial scaffolds. Bioinks innovation is one of our specialties. We offer a portfolio of bioinks that consists of PEG Acrylates, PEG Methacrylate’s, PEG Acrylamides, functionalized PEGs and copolymers of PEG with PLGA and Caprolactone. These bioinks can be customized to meet the needs to the customers including molecular weight, viscosity etc. If you’re looking for specialty polymers for 3D printing, please get in touch to discuss your application requirements.

Caroline Lauret 

blank

Caroline Lauret joined Evonik in 2018 as a Senior Business Manager for Medical Devices. Caroline’s expertise lies in the field of medical device applications and she has been active in this market for more than 15 years. Caroline studied Biomedical Engineering at the Technical University Eindhoven, the Netherlands, and obtained her Master’s degree in Material Sciences. She has a strong background in global sales management, Medical Devices, Polymer Technology, and Materials Science.

Thiago Borges

blank

Dr. Thiago Borges is manager for customer projects at Evonik’s biomaterials center in Birmingham, Alabama. He has 13 years of experience in the medical device industry and is responsible for managing customer projects, providing technical application support, and managing internal innovation projects for medical device solutions. Thiago joined Evonik in 2015 and was previously a project manager for RESOMER¼ Filament and other products where he coordinated the development of technical grade and GMP grades for this product. Prior to Evonik, he worked for eight years in the medical device industry holding different positions in R&D and operations, in particular working with stents and embolization devices. Thiago holds a bachelor’s degree in Chemistry from University of Sao Paulo, and a PhD in Polymer Science & Engineering from Case Western Reserve University in the U.S.

Ben Hartkopp

blank

Ben Hartkopp is an inventor and co-inventor of a new kind of 3D printing system capable of jetting extremely viscous materials. The first application that this system addresses is printing photorealistic, full dentures in a single process with a far less post process than current systems on the market. He currently focuses on patent writing and strategy, test design, and research and development.

Moderator:

Dr. Jenny Chen

jenny chen

Dr. Jenny Chen is trained as a neuroradiologist, founder/CEO of 3DHEALS. Her main interests include next generation education, 3D printing in the healthcare sector, automated biology, artificial intelligence. She is an angel investor who invests in Pitch3D companies.

blank

Metal 3D Printing

Metal 3D printing for medical devices is continually on the rise as physicians, technologists, and researchers are increasingly taking advantage of the technology’s boundless flexibility. 3D printed metal implants especially in orthopedics and craniomaxillofacial (CMF) space are some of the earliest devices gaining FDA clearance and wider manufacturing adoption. Biocompatibility of metal/metal alloy, advancement in metallurgy, innate design freedom, and mass customization option offered by 3D printing suggest potential future better implants that could result in greater surgical success and clinical outcome. As the industry progresses, newer or improved manufacturing processes promise a new generation of healthcare applications.

Speakers:

Fabio Sanches Sant’Ana

blank

Fabio Sant’Ana has Precision Mechanics degree and Business Administration Bachelor’s , born and raised in SĂŁo Paulo he has 30 years experience in helping companies to aquire and take full advantage of 3d Machining and Additive Manufacturing Equipment . Entrepreneur and knowledge avid is member of stardarts organizations ASTM F42 Additive Manufacturing , ABNT CEE-261 Manufatura Aditiva e ABNT CB-26 Odonto-MĂ©dico-Hospitalar . CAD/CAM , Surface Modelling and EBM specialist he is passionate in connect people and companies to the right tools to accomplish the mission.

Kuntay AktaƟ

blank

I am passionate technology executive, leader and strategist. I am expert in additive manufacturing, medical 3D Printing, AM technology implementations and applications. I am co-founder of BTech Innovation, who spinned of 3 AM startups already including TrabTech (developing additive manufactured Implants) AddPark (industrial product development and Additive Manufacturing Centre) and Earfit ( customer in ear monitors). I have an engineering background and interested with Metal 3D Printing, new alloys, process development and Metal 3D Printing applications.

Adam Steege

blank

Adam founded his first company, Agile EndoSurgery, in 2010 focused on the development of an enhanced dexterity laparoscopic surgical device. Through this experience, along with the development of several other medical devices currently on the market, Adam learned of both the promise and challenges of 3D printing in medtech, and founded Trio Labs to solve this gap. With over 80 pending and issued patents and 10 years of medical device development experience, he brings a unique perspective to the space of metal AM.

Ken Gall

blank

Professor Gall’s expertise is in mechanical engineering design and materials science. His research has a particular emphasis on the creation, modification, understanding, and commercialization of synthetic biomaterials. He is/was a founder and director of multiple start-ups in the medical device space.

Moderator

Tuan TranPham

blank

Tuan TranPham is the Chief Revenue Officer (CRO) at AZUL 3D, Inc, and prior to that he spend 19 years working for seven of the largest 3D printing companies, such as Z Corp, 3D Systems, Objet, Stratasys, Arcam (a GE company), Desktop Metal and AREVO.

blank

Healthcare 3D Printing Ecosystem: India

In this lightning round, we would like to connect experts from the Indian healthcare 3D printing ecosystem with 3DHEALS audiences around the world, highlighting their breakthroughs, and entrepreneurial lives, and opening new conversation channels on partnerships. We have curated a group of highly diverse and representative panelists from dental 3D printing, medical 3D printing, and bioprinting space. While it is impossible to really dive deep into the entrepreneurial culture and ecosystem of the community without actually physically being there, we aim to bring the most influential voices to the virtual event to give everyone a taste of what it is like to invest in, work for, and partner with Indian startups in the space.

Speaker:

Mahesh Kappanayil

blank

Dr.Mahesh Kappanayil is a Professor of Pediatric Cardiology at Amrita Institute of Medical Sciences and Research Center, Kochi, Kerala, India. He is also the founder and lead of the 3D Printing, Virtual Reality and Innovation Laboratory at Amrita. As a pediatric cardiologist, he has been involved with various facets of the field including high-end transcatheter interventions, advanced cardiac imaging and clinical research. He helped establish India’s first dedicated cardiac MRI program for congenital heart diseases at Amrita. He has been involved in exploring the application of 3D+ technologies in Healthcare for well over a decade. In 2015-16 he helped establish the region’s first “Point-of-Care” medical 3D printing Lab at Amrita, and in 2020-21 expanded the scope of the lab to Extended Reality applications for medicine. These Labs today are hub of multi-disciplinary innovations in leveraging 3D+ technologies for healthcare applications. He believes that technology is a great equaliser, and cutting-edge technologies of 3D Printing and Extended Reality are set to revoutionalise medicine and healthcare in a big way, even in limited resource environments. Dr.Mahesh has won several national awards and recognitions for his work in this area, and has numerous expert lectures and publications to his credit.

Piyush Padmanabhan

blank

Piyush’s journey into the world of Bioprinting began with his experience in the organ transplantation sector. Post his under graduation from Vellore Institute of Technology, Piyush began his career in the pharmaceutical sector at Biocon Limited and then at Roche Pharmaceuticals, where he worked closely with physicians and transplant coordinators in Kidney and Liver Transplants. The ever-widening gap in organs available for transplant and the need for these organs was very apparent to him. This led him to begin Next Big Innovation LabsÂź with Alok and Pooja, the other two co-founders of the company. In his role as the CEO and Co-Founder of Next Big Innovation LabsÂź, Piyush has led various deep technology projects in bioprinting and has also played a pivotal role in raising central and state government funding for the company. Some of the projects he has led are the following: the development of India’s first customized 3D Bioprinter, the development of unique temperature control fixtures for diverse bioprinting components and AI/ML integration into Trivima Bioprinting Systems. Piyush currently holds two technology patents and one process patent in the domain of bioprinting and considers himself to be an eternal student. His goal is to one day bridge the gap in the organ transplantation sector and believes in deep collaborations to achieve this goal.

Mahesh Dhoka 

blank

I have done post my bachelors, taxation, and law along with business management. later joined family business where we are making high purity iron powders and flakes for food, pharma, aerospace and engineering industries exporting to about 30 countries across the world. started 3D Incredible in 2017 with an idea to bring this technology to the masses in India specially with respect to medical applications. so far we have done close to 1400 implants across more than 30 cities in India working and promoting 3d printing with close to 700 surgeons. with respect to engineering, we work with companies across various sectors right from prototyping to small batch production.

Yearla Srinivasa Rao

blank

Yearla Srinivasa Rao is presently working as a chief operating officer of Medoja Health Private Limited, which is a healthcare company with a focus on 3D printing of patient-specific bespoke customized implants using novel biomaterials, and manufacturing of biomaterials from natural sources for medical 3D printing applications. Bone defects are filled with ceramic granules traditionally in many cases, without considering the shape fidelity to the defect or providing vascular supply. Medoja addressed this by using a ceramic composition which can be 3D printable to address shape fidelity and generate vascular supply to it. Yearla completed his Ph.D. from the University of Hyderabad and has overall 6+ years of post PhD industrial experience in nanomaterials and biomaterials based product development for agriculture, cosmetic, nutraceuticals, and pharmaceutical industries. He managed project activities from BIRAC and DBT during his tenure in the industry along with working in a multidisciplinary environment to manage sales, marketing, production, and business development, teams.

Dr. Jatin Kakrani

blank

Co-Founder – Smiles.ai 

Certified Dental Implant & Digital dentistry trainer 

DCI accredited speaker 

Gold Medalist Prosthodontist |

Moderator: 

Firoza Kothari

blank

Firoza Kothari, Co-Founder & CTO – Anatomiz3D Medtech Pvt. Ltd. – A B.Tech in Biotechnology Engineering and now Forbes 30 under 30 – Asia – Healthcare and Science, 2020, Firoza Kothari started her journey to provide patient-specific medical solutions and one day end the organ donation problem by creating live organs out of patients’ stem cells. With that aspiration, she gave birth to Anatomiz3D, a startup focusing on medical 3D printing. She, along with her team, was the first to execute soft tissue models in India through Paediatric Cardiology, partial amputee prosthetic hand, the first kidney tumor case in India, and the model for tongue cancer was the first in the world. Being a Co-founder and CTO of Anatomiz3D, she, along with her team, has successfully added 2000 plus case studies. Her multi-disciplinary expertise prevails in converting 2D DICOM CT/MRI/Echo Scans to 3D Printed anatomical replicas, medical devices, and allied products, using various combinations of Hardware and Software, across multiple medical specializations. Anatomiz3D has played a vital role in creating the market for 3D Printing in the Medical industry in India since 2015 and is a pioneer for the same, also being the first in India to enable Hospital-Industry partnerships for Point-of-Care Labs.

blank

3D Printing for Veterinary Medicine

According to American Pet Product Association (APPA), the current pet-related product industry is worth more than 100 billion dollars, where one-third is veterinary-related products based on 2020 data. There is a steady growth of this remarkable industry, but there are definitely more pet owners now than ever after the pandemic. Some interesting veterinary-related data can be found here.

According to AVMA, Vets experienced a 50% increase in new pets per week Mar-Aug. 2020. Similar to human society, the pet market experiences similar supply chain and manufacturing challenges. Can 3D printing provide better, more efficient veterinary care and a more robust supply chain than the traditional way of things?

Speakers:

Alexander Then

blank

Alexander is a Veterinary Surgeon since 2015 with main interest in Diagnostic Imaging. He has undertaken Master Degree classes in CT, MRI, ultrasonography and nuclear medicine. These courses where a part of a program which is called Imaging and Functional Medicine and are mainly aimed for human doctors and radiology nurses. Further, he finished a 1.5 years long post graduate program for engineers that allows him to use the title of a 3D Printing Specialist. He has been doing 3D Printed jigs with the surgical planning at the 200+ employee Small Animal Hospital in Gothenburg, Sweden for over a year now and is keen to do even more. Recently he also started the first veterinary company in the Nordic countries which today is focused on offering guide systems with 3D printed jigs for veterinary professionals to make the surgical procedures easier and much more precise.

Andrew Allshorn

blank

Andrew Graduated Wolverhampton School of Art and Design with a Degree in Product Design. In 1994 he started his career in AM/3D Printing running an SLA250 and Vacuum system at Liverpool University, before being offered the position of Applications Engineer at 3D Systems introducing 3DPrinting all over the world. After nearly 30 years in the industry Andrew is still running his own company and is extremely passionate about promoting AM via STEAM Education and getting children involved at schools and colleges. Education is the way forward for this industry and it is also the AMUG philosophy for its members. He is a problem solver and love nothing more than helping develop new applications for all industries For the past three years Andrew has served in the Vice President position for AMUG and he also sits on the TCT Expert Advisory Board and is involved in their Bright Minds Initiative at the TCT3Sixty event, as well as being a Create Education Ambassador where he visits schools to educate children about our amazing industry.

Johnny Uday

blank

I am a Veterinarian Surgeon passionate about 3D printing; currently working designing and manufacturing patient specific implants for human/animal use.

Dr. Kalman Czeibert

blank

After graduation, he worked as a clinician veterinarian in a small animal hospital. In 2012, he joined the Department of Anatomy and Histology at the University of Veterinary Medicine, Budapest, to teach veterinary anatomy. In 2016, he became a research member of the Senior Family Dog Project at the ‘ELTE’ Eotvos Lorand University, which investigated canine cognitive dysfunction with an international ERC group. He defended his Ph.D. thesis on canine neuroanatomy and 3D modelling, and due to his interest in these topics, he coordinates the Canine Brain and Tissue Bank and regularly assists in small animal brain surgeries. Currently, he is working at LimesVet Ltd. in a research-innovation-development position to create custom-made veterinary equipment and integrating digital modelling, 3D printing and anatomical visualization into the routine clinical, research and educational life.

Moderator:

Richard Doerer

blank

Richard Doerer is the 3DHEALS Detroit Community Manager. He is the founder of Modl3D, LLC, a medical technology company specializing in 3D printing and medical imagery for veterinary practices and education. Recent projects include canine nasal sarcomas, brain meningiomas, and aneurysms in the caudal cava.

Richard made a career change to work in the medical field after hearing Dr. David Zopf at a Materialise event in Detroit. Dr. Zopf was a recent speaker at the 3DHEALS Detroit event at the University of Michigan in January 2020. 

A former Yale School of Architecture faculty member in architectural model building, Richard has been involved with 3D printing since the early 1990s with SLA’s from 3D Systems.

In addition to his work with Modl3D, Richard is the Additive Lab Manager/Engineering Manager for Adient, LLC. Adient, LLC is the largest global automotive seat manufacturer.  

Richard is an automotive industry expert featured on numerous panel discussions and holds numerous patents for innovative automotive applications. He is a graduate of Michigan State University, MBA and Yale School of Art, MFA.

blank

3D Printing for Cardiovascular System

The cardiovascular system indisputably dictates the fitness level and longevity of any individual. It is also one of the top killers and debilitating conditions of modern human beings no matter where you live. “Heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. One person dies every 36 seconds in the United States from cardiovascular disease. About 659,000 people in the United States die from heart disease each year—that’s 1 in every 4 deaths. Heart disease costs the United States about $363 billion each year from 2016 to 2017. This includes the cost of health care services, medicines, and lost productivity due to death.” [https://www.cdc.gov/heartdisease/facts.htm] But heart disease has many causes, one of which includes iatrogenic causes, a result of modern medicine. Cardiotoxicity is one of the major side effects of many cancer drugs, for example. Can 3D Bioprinting rejuvenate our hearts? To answer this question, we have invited one of the most comprehensive world-class experts from academia, industry, startup world to engage with the audiences on the possibilities of this emerging technology in solving a critical problem, topic including and not limited to bioprinting “mini-hearts”, “heart components”, “cardiac repair patch”, among others.

Speakers:

Vahid Serpooshan

blank

Vahid Serpooshan did his BSc and MSc in Materials Science and Engineering at Sharif University (Tehran, Iran, 1998-2003) and his Ph.D. in biomaterials and tissue engineering at McGill University (Montreal, Canada, 2007-2011). His Ph.D. thesis research focused on the design and optimization of scaffolding biomaterials for bone tissue engineering applications. Following his Ph.D., Dr. Serpooshan worked for 7 years at Stanford University School of Medicine as Postdoctoral Fellow (Pediatric Cardiology) and Instructor (Stanford Cardiovascular Institute). At Stanford, Dr. Serpooshan’s training and research were mainly centered on developing a new generation of engineered cardiac patch devices to repair damaged heart tissue following myocardial infarction (heart attack). The engineered patch was successfully tested in mouse and pig models and is now in preparation for clinical trials. He also worked on enabling technologies for human-machine hybrid cardiac tissue, using 3D bioprinting to assemble complex arrays of interfaces between synthetic and biological materials. In 2018, Dr. Vahid Serpooshan joined Emory University and Georgia Institute of Tech as Assistant Professor of Biomedical Engineering and Pediatrics, where his multidisciplinary team is now working on a variety of 3D bioprinting-based tissue engineering and disease modeling projects.

Asaf Toker

blank

Asaf is a pediatrician with years of experience in the biotechnology industry. For the last 3 years, Asaf is the CEO of Matricelf, an Israeli publicly-traded company in the area of tissue engineering and regenerative medicine.

Carmine Gentile

blank

Dr Carmine Gentile, PharmD/Ph.D., FAHA, received his BSc/MSc (Pharmaceutical Chemistry and Technologies) and PharmD at the University of Pisa, Italy, and his Ph.D. in Biomedical Sciences (Cardiovascular) at the Medical University of South Carolina, Charleston, SC, USA, funded by a prestigious American Heart Association Fellowship. Since 2013, Dr. Gentile has worked in Australia at the Heart Research Institute, the University of Sydney, and now at UTS, supported by several awards and grants, working within a multidisciplinary team with scientists, industry partners, and clinicians to quickly translate his findings from bench to bedside. He currently leads the Cardiovascular Regeneration Group (www.gentilelab.com), working on 3D bioprinting and stem cell technologies for cardiovascular tissue applications both at the Kolling Institute/University of Sydney and UTS. He is a Senior Lecturer (Honorary) within the Sydney Medical School (Northern) at the University of Sydney and a Senior Lecturer (Faculty) within the School of Biomedical Engineering (Faculty of Engineering and IT) at the University of Technology Sydney. 

Dr. Gentile is an internationally recognized expert in the field of 3D bioprinting and stem cell technologies and his more recent studies focus on novel molecular and cellular approaches to treat cardiovascular disease, including myocardial infarction and heart failure. These studies are based on the use of vascularized cardiac spheroids or “mini-hearts” he developed as “bio-inks” for human heart tissues. In 2016, he was invited as Visiting Research Fellow at Harvard Medical School, where he worked towards novel in-vitro models using mini-hearts to study human heart physiology.

Adam Feinberg

blank

Dr. Adam Feinberg is Co-Founder and CTO of FluidForm Inc, a start-up company commercializing FRESH 3D bioprinting technology, and a Professor at Carnegie Mellon University in the departments of Biomedical Engineering and Materials Science & Engineering. He earned his BS in Materials Science & Engineering from Cornell University in 1999 with Co-op experience at Abiomed, Inc., working on total artificial hearts. He then earned his Ph.D. in Biomedical Engineering from the University of Florida, focused on engineering cell-material interactions to prevent and enhance adhesion. This was followed by postdoctoral training at Harvard University, developing new biomaterials and stem cell-based cardiac tissue engineering strategies. Dr. Feinberg has co-authored over 50 peer-reviewed publications, holds over 20 US patents and patent applications, and has received multiple honors including the NSF CAREER Award, the NIH Director’s New Innovator Award, and Fellow of the American Institute for Medical and Biological Engineering. A primary research focus is engineering extracellular matrix (ECM) protein scaffolds using advanced biomanufacturing and 3D bioprinting approaches for multiple applications including cancer models, regenerative scaffolds, skeletal muscle, and cardiac muscle tissue engineering. At FluidForm, he is driving the commercialization of the FRESH 3D bioprinting platform for a wide range of applications in the biopharma, medical device, and regenerative medicine industries.

Moderator:

William Harley

blank

William is a Ph.D. candidate within the School of Biomedical Engineering at the University of Melbourne. He obtained a Certificate 3 in Business Management and an Honors Degree in Medical Biotechnology from the University of New South Wales where he first entered research focusing on biomaterials, stem cells, and nanofabrication processes for tissue regeneration. Currently, his Ph.D. investigates the use of acoustic micromanipulation and 3D bioprinting as tools to pattern and define the cellular microenvironment. William has held roles as a research assistant and a business development consultant, where he currently serves as a Community and Events Manager for 3D Heals and an Organizing Committee Member for the Australian Bioprinting Workshop.

blank

3D Bioprinting Cancer

Cancer, what a modern-day existential threat to humanity, is a word that triggers a cringe from the most fearless. Over the past decades in modern medicine, we have made much progress in cancer care, ranging from diagnosis, surgical advancements, to therapeutics. Despite that, cancer is surpassing heart diseases as a leading cause of death in the United States in 2020. [Ref] The demand for faster diagnostics and better treatment is driving researchers to technologies like 3D printing and 3D bioprinting. 

Speakers:

Dr. Antti Arjonen

blank

Cancer research, microscopy, cell biology, image-based high-throughput screening, 3D bioprinting

Dr. Karolina Valente

blank

Karolina has a B.Sc. and M.Sc. in Chemical Engineering, and a Ph.D. in Mechanical Engineering. She has deep expertise in tissue engineering, 3D bioprinting, and oncology. Karolina has published multiple peer-reviewed papers and is currently an Assistant Teaching Professor at the University of Victoria and the CEO & CSO of VoxCell BioInnovation.

Raphael Lichtnecker

blank

I got my MasterÂŽs degree in Pharmaceutical Bioprocess Engineering at Technical University Munich. Afterwards I started as Business Development Manager at ViscoTec where I am responsible for the technology transfer of the progressive cavity pump to the bioprinting sector. IÂŽm in this position for four years now.

Moderator:

Dr. Jenny Chen

jenny chen

Dr. Jenny Chen is trained as a neuroradiologist, founder/CEO of 3DHEALS. Her main interests include next generation education, 3D printing in the healthcare sector, automated biology, artificial intelligence. She is an angel investor who invests in Pitch3D companies.

blank

3D Printed Prosthetics

Over the years, the images of disabled children with colorful prosthetic limbs inspired impactful movements like the ENABLE community and Victoria Hand Project, as well as enumerable passionate innovators who have pushed the boundaries to increase accessibility and lower the cost of orthotics and prosthetics. However, the field of 3D printed prosthetics has advanced significantly since the days of ENABLE hands. These advancements include not just hardware, materials, but also software, designs, 3D scanning, and lately completely digitalized workflow at the point of care, often leveraging machine learning and artificial intelligence. More importantly, technologists are now working more closely with clinicians to create a more efficient and more evidence-based patient-centered clinical solution. In this highly anticipated webinar, we invited experts with decades of technical, business, and clinical experiences and diverse perspectives to give the attendees a 360-degree view of the current and future status of the industry. 

Speakers:

Bryan Craft

blank

Bryan Craft started his career in medical 3D technology during a time where Coronavirus was threatening the supply of critical medical equipment (PPE). Working with a service bureau in North Carolina, he and his team 3D printed and delivered thousands of face shields to medical professionals in North Carolina and beyond. Bryan has devoted his time to learn how the 3D technology industry can improve medical device manufacturing specifically for Orthotics and Prosthetics. In 2021, Bryan joined the medical technology company, Spentys, where he is making 3D technology a reality in O&P. His core focus is to enhance the patient experience by increasing customization, exploring advanced materials, and working closely with innovative clinicians. Bryan has investigated the time savings for clinicians who adopt streamlined 3D technology and continues to search for new applications and use cases.

Albert Shih

blank

Albert Shih is Professor in Mechanical Engineering, Biomedical Engineering, and Institute of Gerontology at the University of Michigan. He received PhD from Purdue University in 1991 and was a manufacturing engineer at Cummins and an Associate Professor at NC State University before joining the University of Michigan in 2003. He served in the Advanced Manufacturing National Program Office in 2017 and was the President of NAMRI SME in 2019-2020. Dr. Shih is a pioneer in biomedical manufacturing. He is the recipient of the Fulbright Scholar, SAE Teetor Educational Award, SME Taylor Research Medal and Education Award, and ASME Shaw Manufacturing Research, Blackall Machine Tool & Gage Award, and Ennor Manufacturing Technology Award. Professor Shih is the Fellow of ASME, SME, and CIRP.

Michael Peirone

blank

Michael started volunteering with Victoria Hand Project when it was still a university research project, and has seen it grow across the world. Through his years with VHP, Michael has gotten a broad view of the organization as a volunteer, student intern, Biomedical Designer, the COO, and most recently taking on the role of CEO.

Samer Moussa

blank

Samer Moussa has a background that merges design, clinical care, and business development of medical devices. With an undergrad in Mechanical Engineering, a Masters of Science in Orthotics and Prosthetics and currently pursuing an MBA, he has transitioned from everyday clinical care as a CPO to working as a product manager with different medical device manufacturers. From adjustable prosthetic sockets with LIM Innovations to innovative off-the-shelf knee and spine devices with Breg and the latest venture with HP, Arize Orthotics which is a fully developed end-to-end solution for custom orthotics. Samer has been in the O&P industry for 10 years and his main passion is finding the right bridge between new technology and clinical pain points in a way that both businesses can strive.

Prof. Dr. Hans-Werner Schmidt

blank

Hans-Werner Schmidt studied Chemistry at the University of Mainz (Germany) and ETH ZĂŒrich (Switzerland). He received his Dr. rer. nat. degree in Macromolecular Chemistry at the University of Mainz. After a stay at the DuPont Central Research in Wilmington, Delaware he moved to the University of Marburg to obtain his Habilitation. From 1989 to 1994 he was Assistant and Associate Professor of Materials with tenure at the Materials Department, College of Engineering at the University of California, Santa Barbara. Since 1994 he is Full Professor for Macromolecular Chemistry at the University of Bayreuth. He was Vice President for research at the University of Bayreuth and is founding director of the Bavarian Polymer Institute. He has many years of research experience in the development of polymer materials for emerging technologies. For over 10 years, he has been involved in the development of materials for additive manufacturing. As co-founder of the German based company PPprint, he is actively involved in the development of 3D printing materials for applications in medical technology.

Moderator:

Dr. Jenny Chen

blank

Dr. Jenny Chen is trained as a neuroradiologist, and founder/CEO of 3DHEALS. Her main interests include next-generation education, 3D printing in the healthcare sector, automated biology, and artificial intelligence. She is an angel investor who invests in Pitch3D companies.

blank

3D Printing in Hospitals

In recent years, many hospitals have started making a shift, from using medical images primarily for diagnostic purposes, to integrating them in patient-specific surgical planning. This has created enormous advantages for hospitals and their patients and is largely supported by the clarifying regulatory landscape, increased governmental support, new public and private initiatives, and the expanding role of the radiologist as an imaging expert. As part of this, an increasing number of hospitals across the world have integrated the practice of 3D printing into their medical care. Hospitals are recognizing the added value it brings to personalized patient care and the countless possibilities that are becoming a reality, in creating better treatment options.

Speakers:

Robert Hannan, MD

Director, CV Surgery Advanced Projects Laboratory | Medical Director, Quality, Nicklaus Children’s Health System | Cardiovascular Surgeon, Nicklaus Children’s Hospital

Robert Hannan, MD

Dr. Hannan holds multiple patents of medical devices, and developed Real Time Outcomes described above. His interests include delivery, measurement and transparency of quality medical care, advanced imaging, immersive technologies for patient care, and the use of innovation in clinical care and education.

Shafkat Anwar

Associate Professor of Pediatrics and Radiology, University of California San Francisco

Shafkat Anwar

Dr. Shafkat Anwar is a pediatric cardiologist at the University of California San Francisco. He specializes in non-invasive cardiac imaging, including echocardiography and cardiac magnetic resonance imaging (MRI). At UCSF, he is the Director of the Pediatric Heart Center’s Cardiac MRI and 3D+ Programs. He has founded two hospital-based 3D printing Centers – the first at Washington University in St. Louis, and currently he co-Directs UCSF’s Center for Advanced 3D+ Technologies (CA3D+). He is involved in several national and international collaborations related to 3D modeling and 3D printing. He is a founding member and the inaugural Chair of the Society for Cardiovascular Magnetic Resonance’s Advanced 3D+ Visualization Special Interest Group. Dr. Anwar completed his Residency in Pediatrics at Children’s National Medical Center, followed by a research fellowship at the National Institutes of Health. He completed his Pediatric Cardiology Fellowship at Cleveland Clinic, followed by Fellowship in Cardiac Imaging at Children’s Hospital of Philadelphia.

Muhanad Shraiteh

blank

Muhanad recently graduated with a master’s in bioengineering and a bachelor’s in mechanical engineering. He joined the Cardiovascular Surgery Advanced Projects Lab last year and is working on innovative design and development ideas that have an impact on people’s lives and improve standards of care.. Muhanad’s research interests and past projects include topics such as biomechanics and global health engineering.

Imre J. BarabĂĄs

Imre J. BarabĂĄs

Imre is the leader of the Semmelweis 3D Centre (SE3D) at the most prestigious Semmelweis University in Budapest, Hungary. Imre works as a cardiac surgeon at Semmelweis University while running the center. His Ph.D. topic was a patient-specific 3D printed exoskeleton for left ventricle assist device implantation. Imre has gained experience during the development and licensing of the exoskeleton under the medical device regulation. Imre is the CEO and Founder of the 3D Guide Ltd. using the exoskeleton patent. The SE3D is a facility for 3D printing technology at Semmelweis University based on the three pillars of the university: patient care, education, and research. My mission is to promote 3D printing technology and build community among those clinicians using 3D technology at the university. The capability of 3D technology is a personalized and safer decision-making tool in clinicians’ hands. Imre has introduced a new undergraduate course called Basics of Digital Medicine in 2021. My goal is to give practical knowledge to medical students about 3D technology. The curriculum covers the full spectrum of medical 3D technology, including data capture, DICOM data transformation, segmentation, 3D printing, and post-processing printed objects. 3D printing is still relatively new learning and teaching tool for medical education. Patient-specific models with anatomical fidelity made from imaging datasets can significantly improve a new generation of surgeons’ knowledge and skills. The SE3D Centre offers a cooperation platform between researchers and clinicians under my leadership. My vision is to find new ways to address old and new medical issues through frontier experiments.

Kerim Genc

Kerim Genc

Kerim Genc is the Business Development Manager for the Simpleware Product Group at Synopsys. He joined Simpleware in 2011 and is currently responsible for managing global sales, business development, partnerships and technical marketing content development, with a significant focus on image-based patient specific workflows for 3D Printing and surgical guides/planning. He received his BS and MS in biomechanics from the University of Calgary and the Pennsylvania State University respectively, and completed his PhD in Biomedical Engineering at Case Western Reserve University, examining countermeasures to and computational models of spaceflight induced bone loss and fracture risk.

Thomas Haglund

Thomas Haglund

Thomas’ graduate studies were in cardiac tissue engineering before joining the team at Nicklaus Children’s. Thomas has been instrumental in operationalizing 3D printing and Mixed Reality at the Nicklaus Children’s Hospital since 2018. With the help of generous donors, the CVS APL has touched the lives of hundreds of children and their family.

Dr. Stephen Ryan

blank

Dr. Stephen Ryan is a practicing physician and co-founder of PolyUnity Tech. He has explored Additive Manufacturing applications in healthcare for over 6 years as a researcher and entrepreneur. He has been involved in the creation of many 3D Printed products including medical simulations, patient specific medical devices, PPE and end use hospital equipment. His current role is to build relationships with hospital stakeholders to better understand regulatory considerations and advocate for the adoption of additive manufacturing services within the healthcare ecosystem.

blank

Bioprinting Vasculatures

3D bioprinting vasculatures is perhaps the holy grail of the next industrial revolution in healthcare. Biofabrication and bioprinting of any viable three-dimensional tissue will not be successful unless the vascularization challenge has been solved. Many organizations and talents around the world are actively tackling this challenge, but where are we exactly? Hear the latest perspectives, updates, and revelations from a group of technical and industrial superstars. 

Speakers:

Taci Pereira

blank

Taci Pereira is Vice President and General Manager, Bioprinting at 3D Systems, where she leads the development and commercialization of research tools for 3D bioprinting applications. Taci was previously the Chief Scientific Officer at Allevi, a startup 3D Systems acquired in 2021. Taci leads the 3D bioprinting working group for the Regenerative Medicine Manufacturing Society, a professional society dedicated to advancing manufacturing solutions for the field of regenerative medicine. Originally from Curitiba, Brazil , She holds a Bachelor of Science in Bioengineering from Harvard University, where she worked at the Wyss Institute for Biologically Inspired Engineering. Taci’s research at the Mooney Laboratory for Cell and Tissue Engineering (Wyss) focused on biomaterials for cancer immunotherapy, under the advisory of David Mooney, Ph.D.

Ibrahim T. Ozbolat

blank

Ibrahim Tarik Ozbolat is an Associate Professor of Engineering Science and Mechanics, Biomedical Engineering and Neurosurgery, and a member of the Huck Institutes of the Life Sciences at Penn State University. Dr. Ozbolat’s main area of research is in the field of 3D Bioprinting. He has been working on several aspects of bioprinting such as bioprinting processes, bioink materials, bioprinters and post-bioprinting tissue maturation for manufacturing of more than a dozen tissues and organs. Dr. Ozbolat is a leading scientist with over 150 publications, including a sole-authored book in his domain. Due to his notable contributions to the field of bioprinting, he has received several prestigious international and national awards including 2014 NSF CAREER Award, 2014 SME Outstanding Young Manufacturing Engineer Award, 2014 ASME Chao and Trigger Young Manufacturing Engineer Award, 2014 ASME Tau Pi Sigma Gold Medal, 2015 IIE Dr. Hamid K. Eldin Outstanding Early Career Industrial Engineer in Academia Award, 2015 International Outstanding Young Researcher in Freeform and Additive Manufacturing Award and 2017 Hartz Family Career Development Professorship at Penn State.

Marc Thurner

blank

Marc Thurner is a visionary, entrepreneur and pioneer in biofabrication technologies, currently acting as Chief Executive Officer at mimiX biotherapeutics Ltd. He pioneered the field of 3D bioprinting with his former creation regenHU Ltd, today recognized as an industry leader in the development of innovative biomedical solutions. A micro technology engineer Graduate, Marc started his professional career as an R&D engineer, managing international projects for the high precision automation industry. His avant-gardiste view that the future of regenerative medicine lay in converging engineering and biomedical science, brought him to found regenHU Ltd in 2007 and mimiX biotherapeutics Ltd in 2020. In 2012 Marc created the regenHU spin-off Vivos Dental Ltd, specialized in innovative 3D-printed bone grafting solutions for oral bone augmentation. Being an industry transformation leader, mimiX biotherapeutics develops leading-edge solutions in biotechnology and tissue engineering that enable scientific and clinical breakthroughs. The Swiss-based company collaborates with a global network of scientific innovators and industry players and leads the development of biomedical products for regenerative medicine and drug discovery. Marc Thurner and the mimiX biotherapeutics team are passionate about addressing the current and next generation biotechnology challenges to help the progress of Life Sciences.

Pierre-Alexandre LAURENT, PhD

blank

During my PhD, I worked on the role of PI3Ks on the platelet functions and thrombus formation using in particular microfluidic/videomicroscopy technics. My postdoc research was focused on the development of 3D bone marrow models for the study of thrombocytopenia, developping bioreactor for ex-vivo platelet production and drug testing purposes using silk fibroin biomaterial and 3D bioprinting approach. I am now Senior Field Application Scientist at CELLINK, a BICO company promoting how our amazing bioconvergence technologies contribute to the future of biomedical research.

Moderator:

William Harley

blank

William is a Ph.D. candidate within the School of Biomedical Engineering at the University of Melbourne. He obtained a certificate 3 in business management and an honors degree in medical biotechnology from the University of New South Wales where he first entered research focusing on biomaterials, stem cells, and nanofabrication processes for tissue regeneration. Currently, his Ph.D. investigates the use of acoustic micromanipulation and 3D bioprinting as tools to pattern and define the cellular microenvironment. William has held roles as a research assistant and a business development consultant, where he currently serves as a community and events manager for 3D Heals and an organizing committee member for the Australian Bioprinting Workshop.